Anticancer mechanisms of vitamin E succinate

Chinese Journal of Cancer

Volumn 28, Issue 10, 2009, Pages

  Dong, Yong Heng ^a,b   Guo, Yin Han ^a   Gu, Xin Bin ^b  

^a Oriental TenGen Tech Development Co Ltd   (China)

^b HOWARD UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Anticancer mechanism; Cancer prevention; Cell apoptosis; Vitamin E succinate; tocopheryl succinate

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; CASPASE 8; CYCLIN D1; CYTOCHROME C; FAS LIGAND; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; K RAS PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PROTEIN BCL 2; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F1; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HYDROPHOBICITY; METASTASIS; ONCOGENE RAS; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 77949496860     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.008.10182     Document Type: Review

References (50)

1. Neuzil J, Weber T, Gellert N, et al. Selective cancer cell killing by alpha-tocopheryl succinate [J]. Br J Cancer, 2001, 84 (1): 87-89.
2. Crispen PL, Uzzo RG, Golovine K, et al. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention [J]. Prostate, 2007, 67(6): 582-590.
3. Tomasetti M, Rippo MR, Alleva R, et al. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells [J]. Br J Cancer, 2004, 90(8): 1644-1653.
4. Stapelberg M, Tomasetti M, Alleva R, et al. alpha-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors [J]. Biochem Biophys Res Commun, 2004, 318(3): 636-641.
5. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1 [J]. Nutr Cancer, 2002, 43(2): 227-236.
6. Wu K, Zhao Y, Liu BH, et al. RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest [J]. World J Gastroenterol, 2002, 8(1): 26-30.
7. You H, Yu W, Sanders BG, et al. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation [J]. Cell Growth Differ, 2001, 12(9): 471-480.
8. You H, Yu W, Munoz-Medellin D, et al. Role of extracellular signal-regulated kinase pathway in RRR-alpha-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells [J]. Mol Carcinog, 2002, 33(4): 228-236.
9. Ni J, Chen M, Zhang Y, et al. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery [J]. Biochem Biophys Res Commun, 2003, 300(2): 357-363.
10. Gu X, Song X, Dong Y, et al. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo [J]. Clin Cancer Res, 2008, 14 (6): 1840-1848.
11. Gu X, Schwartz JL, Pang X, et al. Cytotoxicity of liposomal alpha-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture [J]. Cancer Lett, 2006, 239(2): 281-291.
12. Stapelberg M, Gellert N, Swettenham E, et al. Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress [J]. J Biol Chem, 2005, 280(27): 25369-25376.
13. Otsu K, Sato K, Ikeda Y, et al. An abortive apoptotic pathway induced by singlet oxygen is due to the suppression of caspase activation [J]. Biochem J, 2005, 389(Pt 1): 197-206.
14. Schwartz J, Baker V, Larios E, et al. Inhibition of experimental tobacco carcinogen induced head and neck carcinogenesis [J]. Oral Oncol, 2004, 40(6): 611-623.
15. Wu K, Zhao L, Li Y, et al. Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance [J]. World J Gastroenterol, 2004, 10(7): 945-949.
16. Weber T, Dalen H, Andera L, et al. Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling [J]. Biochemistry, 2003, 42 (14): 4277-4291.
17. Malafa MP, Fokum FD, Smith L, et al. Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate [J]. Ann Surg Oncol, 2002, 9(10): 1023-1032.
18. Neuzil J, Weber T, Schroder A, et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements [J]. FASEB J, 2001, 15 (2): 403-415.
19. Wu K, Li Y, Zhao Y, et al. Roles of Fas signalling pathway in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells [J]. World J Gastroenterol, 2002, 8 (6): 982-986.
20. Kline K, Yu W, Sanders BG. Vitamin E: mechanisms of action as tumor cell growth inhibitors [J]. J Nutr, 2001, 131(1): 161S-163S.
21. Yu W, Liao QY, Hantash FM, et al. Activation of extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-α-tocopheryl succinateinduced apoptosis of human breast cancer cells [J]. Cancer Res, 2001, 61 (17): 6569-6576.
22. Zu K, Hawthorn L, Ip C. Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cells [J]. Mol Cancer Ther, 2005, 4(1): 43-50.
23. Bang OS, Park JH, Kang SS. Activation of PKC but not of ERK is required for vitamin E-succinate-induced apoptosis of HL-60 cells [J]. Biochem Biophys Res Commun, 2001, 288 (4): 789-797.
24. Wang XF, Witting PK, Salvatore BA, et al. Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway [J]. Biochem Biophys Res Commun, 2005, 326(2): 282-289.
25. McLennan HR, Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species [J]. J Bioenerg Biomembr, 2000, 32 (2): 153-162.
26. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria [J]. Cancer Res, 2003, 63 (10): 2483-2491.
27. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment [J]. Nat Rev Cancer, 2004, 4(8): 604-616.
28. Neuzil J. Alpha-tocopheryl succinate epitomizes a compound with a shift in biological activity due to pro-vitamin-to-vitamin conversion [J]. Biochem Biophys Res Commun, 2002, 293(5): 1309-1313.
29. Neuzil J, Weber T, Schröder A, et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements [J]. FASEB J, 2001, 15(2): 403-415.
30. Neuzil J, Zhao M, Ostermann G, et al. Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability [J]. Biochem J, 2002, 362(Pt 3): 709-715.
31. Pussinen PJ, Lindner H, Glatter O, et al. Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells [J]. Biochim Biophys Acta, 2000, 1485(2-3): 129-144.
32. Neuzil J, Dong LF, Wang XF, et al. Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells [J]. Biochem Biophys Res Commun, 2006, 343(4): 1113-1117.
33. Kozin SV, Shkarin P, Gerweck LE. The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics [J]. Cancer Res, 2001, 61 (12): 4740-4743.
34. Donapaty S, Louis S, Horvath E, et al. RRR-alpha-tocopherol succinate down-regulates oncogenic Ras signaling [J]. Mol Cancer Ther, 2006, 5(2): 309-316.
35. Dalen H, Neuzil J. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappa B activation [J]. Br J Cancer, 2003, 88(1): 153-158.
36. Turley JM, Fu T, Ruscetti FW, et al. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells [J]. Cancer Res, 1997, 57 (13): 881-890.
37. Yu W, Israel K, Liao QY, et al. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43, 000 Fas in VES-triggered apoptosis [J]. Cancer Res, 1999, 59(4): 953-961.
38. Wu K, Liu BH, Zhao DY, et al. Effect of vitamin E succinate on expression of TGF-beta1, c-Jun and JNK1 in human gastric cancer SGC-7901 cells [J]. World J Gastroenterol, 2001, 7(1): 83-87.
39. Shim M, Eling TE. Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism. Mol Cancer Ther, 2008, 7(4): 961-971.
40. Kogure K, Hama S, Manabe S, et al. High cytotoxicity of α-tocopheryl hemisuccinate to cancer cells is due to failure of their antioxidative defense systems [J]. Cancer Lett, 2002, 186 (2): 151-156.
41. Kogure K, Morita M, Nakashima S, et al. Superoxide is responsible for apoptosis in rat vascular smooth muscle cells induced by α-tocopheryl hemisuccinate [J]. Biochim Biophys Acta, 2001, 1528 (1): 25-30.
42. Swettenham E, Witting PK, Salvatore BA, et al. α-Tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system [J]? J Neurochem, 2005, 94(5): 1448-1456.
43. Neuzil J, Tomasetti M, Mellick AS, et al. Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effect [J]. Curr Cancer Drug Targets, 2004, 4(4): 267-284.
44. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria [J]. J Cell Physiol, 2003, 195(2): 158-167.
45. Shiau CW, Huang JW, Wang DS, et al. Alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function [J]. J Biol Chem, 2006, 281(17): 11819-11825.
46. Folkman J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med, 1971, 285(21): 1182-1186.
47. Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy [J]. J Surg Res, 2000, 93(1): 163-170.
48. Zhang M, Altuwaijri S, Yeh S. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene [J]. 2004, 23(17): 3080-3088.
49. Neuzil J, Swettenham E, Wang XF, et al. Alpha-tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling [J]. FEBS Lett, 2007, 581(24): 4611-4615.
50. Ni J, Mai T, Pang ST, et al. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer [J]. Clin Cancer Res, 2009, 15(3): 898-906.